Literature DB >> 15147286

Glucose levels observed in daily clinical practice induce endothelial dysfunction in the rabbit macro- and microcirculation.

Marília B Gomes1, Felipe S Affonso, Solange Cailleaux, Andressa L F Almeida, Leonardo F C Pinto, Eduardo Tibiriçá.   

Abstract

We investigated whether different concentrations of elevated glucose - corresponding to levels observed in patients with type 2 diabetes under routine care (post-prandial mean and maximum values) and those used for diagnosing diabetes - induce impairment of vascular reactivity of the macro- and microcirculation in non-diabetic rabbits. Aortic rings and isolated perfused kidneys from normal rabbits were acutely exposed (3 h) to normal (5.5 mm) or high (7-25 mM) D-glucose concentrations. Vascular reactivity was evaluated with endothelium-dependent [acetylcholine (ACh) and bradykinin (BK)] and independent [sodium nitroprusside (SNP)] vasodilating agents. Endothelium-dependent relaxation of the thoracic aorta induced by ACh or BK was significantly attenuated after a 3-h exposure to high D-glucose (15-25 mM) but not after corresponding increased osmolarity with mannitol solutions. Relaxation induced by SNP (endothelium-independent) was not affected by high D-glucose concentrations. Moreover, endothelium-dependent but not independent vasodilation of the isolated rabbit kidney was also impaired after 3-h perfusion with high D-glucose (11.1-25 mM). Perfusion with mannitol solutions (15-25 mM) partially blunted endothelium-dependent renal vasodilation. It is concluded that acute hyperglycemia corresponding to post-prandial levels in patients with type 2 diabetes induces endothelial dysfunction of conduit vessels as well as of the renal circulation of non-diabetic rabbits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147286     DOI: 10.1111/j.1472-8206.2004.00248.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  8 in total

1.  Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig.

Authors:  R Kelly; T Ruane-O'Hora; M I M Noble; A J Drake-Holland; H M Snow
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

2.  Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.

Authors:  Christine Maric-Bilkan; Elizabeth R Flynn; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-26

3.  Metformin prevents the impairment of endothelium-dependent vascular relaxation induced by high glucose challenge in rabbit isolated perfused kidneys.

Authors:  M B Gomes; S Cailleaux; E Tibiriçá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

4.  Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes.

Authors:  A Joshi; O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-11       Impact factor: 3.000

Review 5.  Renal vascular structure and rarefaction.

Authors:  Alejandro R Chade
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

6.  Na+/H+ exchange inhibition with cariporide prevents alterations of coronary endothelial function in streptozotocin-induced diabetes.

Authors:  Guillaume Vial; Hervé Dubouchaud; Karine Couturier; Martine Lanson; Xavier Leverve; Luc Demaison
Journal:  Mol Cell Biochem       Date:  2007-12-05       Impact factor: 3.396

7.  Corticosteroids and endothelial dysfunction.

Authors:  Reza Tabrizchi
Journal:  Vasc Health Risk Manag       Date:  2005

8.  Effect of Influenza Vaccination on the Reduction of the Incidence of Chronic Kidney Disease and Dialysis in Patients with Type 2 Diabetes Mellitus.

Authors:  Li-Chin Sung; Chun-Chao Chen; Shih-Hao Liu; Chun-Chih Chiu; Tsung-Yeh Yang; Cheng-Hsin Lin; Yu-Ann Fan; William Jian; Meng-Huan Lei; Hsien-Tang Yeh; Min-Huei Hsu; Wen-Rui Hao; Ju-Chi Liu
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.